The Patent Finder

Esoterix, Inc. Coagulation

Also on record
Records under this name other than patents Esoterix, Inc. Coagulation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 2 of 2 · Back to Esoterix, Inc. Coagulation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,994,983Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage
Formerly held
Term ended
Term ended Feb 1, 2021 · USPTO record
Term endedTerm ended Feb 1, 2021USPTO record
US 6,967,083Thromboxane B2 metabolite methods for optimizing aspirin dosage
Formerly held
Lapsed on the fee record
Ended Nov 22, 2017 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2017USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited